Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Analysis Shifts in APAC healthcare

The Asia-Pacific (APAC) healthcare industry is undergoing rapid transformation with a dramatic shift in consumer behaviour and expectations, opening up growth opportunities across diagnostics, regenerative medicine, medical tourism and digital health.

The positive growth is fuelled by increasing adoption of new technology, innovative healthcare access programs, and delivery of care outside traditional hospital settings. Frost & Sullivan projects a revenue growth of over 12% in 2018, making APAC one of the fastest growing regions for the healthcare industry in the world.

Frost & Sullivan’s recent analysis, Asia-Pacific Healthcare Outlook, looks at a number of predictions for the APAC healthcare industry.

“Through digital transformation healthcare companies are introducing service-orientated business models, and direct-to-consumer care delivery platforms in the region,” said Natasha Gulati, industry manager, transformational health, Frost & Sullivan. 

“Meanwhile new approaches to health and wellness, like “omics” based health advisory and gamification are gaining market momentum,” she added. 
Gulati recommends players focus on personalisation, combined with consumer empowerment, as a key ingredient for disease prevention and patient wellness. Innovative companies active in this space include Prudential, iCarbonX, and Healthi which are moving toward personalised wellness intervention through the introduction of direct-to-consumer gene sequencing, and Thorne Research and Imagene Labs which are about to make available personalised over-the counter nutritional supplements and skin care products on a subscription model. 

Six key trends spurring growth opportunities in the APAC healthcare industry include: the rise of new payment models, especially those tied to value-based outcomes; fast-tracked innovative therapeutic products, development and penetration of regenerative medicine, biosimilars, and genetics; technology innovation with rapid development in areas like Artificial Intelligence, mHealth, and virtual reality; the development of personalisation combined with consumer empowerment for prevention and wellness; the adoption of wireless real-time monitoring, aided by analytics, as the clinical community aims for further efficiency and outcome-based approaches; and the rapid deployment of cloud solutions to increase IT efficiency in non-clinical departments.

 “An important global trend that is currently missing in APAC is the introduction of value-and outcomes-based payment and reimbursement models. Industry suppliers, including IT vendors, medical technology companies and pharmaceuticals, are partnering with public and private payers to introduce outcomes-based reimbursement models for expensive therapeutic products and services in other parts of the world,” noted Gulati.

Posted on: 14/05/2018 UTC+08:00


News

Chularat Hospital, which operates 13 clinics and hospitals in Thailand, intends to build the Suvarnabhumi Cancer and Radiologist Center Hospital, which will provide specialised medical services to general patients and counterparties in Samutprakan and nearby provinces.
Thomson Medical Group (TMG), Singapore’s second largest healthcare group, has reported EBITDA of S$23.4 million (US$17.1 million) on the back of total revenue for the first half of the year at S$105.5 million.
Healthcare services group Clearbridge Health has reported revenue of S$1.46 million (US$1.1 million) for the three months ended 30 June 2018. The topline growth is nearly four times the S$0.38 million achieved by the group in Q1 and mainly attributed to recent acquisitions including a medical centre in the Philippines in January and in Singapore and Indonesia in April.
Australian hearing implant manufacturer Cochlear delivered net profit of A$245.8 million, an increase of 10% on FY17, which was within the guidance range of A$240-250 million. Chief executive and president Dig Howitt said, “Cochlear continues to deliver on its objective of delivering consistent revenue and earnings growth over time.
Shareholders of Fortis Healthcare, the country’s second largest private hospital chain, have approved the US$584.1 million acquisition plan by IHH Healthcare, Asia’s largest healthcare company – 99.7% voted in favour of the deal.
Retirement village operator Summerset Group Holdings has announced an underlying profit of NZ$45.2 million (US$29.7 million), an increase of 27%, in line with the profit guidance provided in early July.
Leading fully integrated plasma-based biopharmaceutical company China Biologic Products Holdings has appointed Bing Li as chief executive officer. By assuming the CEO position, Li has moved from an independent director to an executive director of the board. Zhijun Tong, the former acting CEO, will continue to serve as an executive director of the board and president of the company.
Beijing-based paediatric healthcare provider New Century Healthcare has taken a 10.1% stake in Chiron Healthcare. Financial terms have not been disclosed.



Analysis

First you must find a clinic space from which to practice. The good news is that space is available at most hospitals. The bad news is that a 1,200 square-foot clinic space at Mount Elizabeth Hospital currently retails for around S$10 million, or US$7.34 million to secure a space less than half the size of a tennis court. By the time you add fittings, equipment and staff, your relationship with your bank manager will likely be under severe strain.
China’s hospital landscape is rapidly changing as operators and owners respond to shifting policy incentives, an aging population, the opportunity to serve Tier 2 and 3 cities, and shifts in consumer preferences.
Today, more and more people are suffering from serious, incurable, and/or rare illnesses. However, access to information on such conditions has been quite limited, to hospitals or internet surfing. Even though there were communities and organizations serving people with certain illnesses, information was not widely available, due to the general nature of the illnesses.
CR Phoenix Healthcare, China’s largest private hospital group, recently announced plans to restructure Beijing Jingmei Group General Hospital, a flagship hospital managed by CR Phoenix under its investment-operation-transfer (IOT) model.
Severe abuses continue in China's organ transplant system – including the sourcing of organs from prisoners of conscience on a large scale – despite Chinese government assertions of reform, finds a new study by the China Organ Harvest Research Center.
Asia Pacific's transition from a volume- to value-based care model has been highly challenging due to the need for large-scale regulatory changes and lack of a funding. Rising healthcare consumerism, digital health adoption, and the growing influence of medical tourism are setting a foundation for population health management, one form of value-based care that shifts the industry focus from episodic, individualised healthcare approaches to collective action against the cost and burden of disease in a society.
Leaders from New Zealand’s health technology industry are looking to Malaysia as a strategic investment opportunity to support the country’s rapidly growing healthcare market.
Ping An Healthcare and Technology, formerly known as Good Doctor, has signed contracts with nearly 200 large corporations, including Vanke, Greentown, Bank of China, China Telecom, China National Nuclear Power, Evergrande Group and provides services to nearly 1.5 million employees, covering 27 provinces, autonomous regions and municipalities.
my images

Podcasts

HealthInvestor Asia twitter feed